Extrawell Pharmaceutical Holdings Limited has announced the grant of a total of 76,500,000 share options to three executive directors: Mr. Cheng Yong, Dr. Lou Yi, and Dr. Guo Yi. Each director will receive 25,500,000 options, representing 1% of the company's total shares in issue at the date of grant. The share options are offered under the company's share option scheme adopted on 2 September 2022. No financial assistance has been provided to the grantees for the subscription of shares under this scheme.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extrawell Pharmaceutical Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251219-11962344), on December 19, 2025, and is solely responsible for the information contained therein.